04 Dec 2015 --- New research published in the December 2015 issue of The FASEB Journal, shows that in mouse models of the disease, oral administration of magnesium-L-threonate (MgT) alleviated cognitive decline by suppressing the Aβ deposition in amyloid plaques.
